位置:首页 > 蛋白库 > TOP1_XENLA
TOP1_XENLA
ID   TOP1_XENLA              Reviewed;         829 AA.
AC   P41512;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   03-AUG-2022, entry version 116.
DE   RecName: Full=DNA topoisomerase 1;
DE            EC=5.6.2.1 {ECO:0000255|PROSITE-ProRule:PRU10130};
DE   AltName: Full=DNA topoisomerase I;
GN   Name=top1;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8836188; DOI=10.1093/nar/24.18.3593;
RA   Pandit S.D., Richard R.E., Sternglanz R., Bogenhagen D.F.;
RT   "Cloning and characterization of the gene for the somatic form of DNA
RT   topoisomerase I from Xenopus laevis.";
RL   Nucleic Acids Res. 24:3593-3600(1996).
CC   -!- FUNCTION: Releases the supercoiling and torsional tension of DNA
CC       introduced during the DNA replication and transcription by transiently
CC       cleaving and rejoining one strand of the DNA duplex. Introduces a
CC       single-strand break via transesterification at a target site in duplex
CC       DNA. The scissile phosphodiester is attacked by the catalytic tyrosine
CC       of the enzyme, resulting in the formation of a DNA-(3'-phosphotyrosyl)-
CC       enzyme intermediate and the expulsion of a 5'-OH DNA strand. TThe free
CC       DNA strand then rotates around the intact phosphodiester bond on the
CC       opposing strand, thus removing DNA supercoils. Finally, in the
CC       religation step, the DNA 5'-OH attacks the covalent intermediate to
CC       expel the active-site tyrosine and restore the DNA phosphodiester
CC       backbone. May play a role in the circadian transcription of the core
CC       circadian clock component ARNTL/BMAL1. {ECO:0000250|UniProtKB:P11387}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP-independent breakage of single-stranded DNA, followed by
CC         passage and rejoining.; EC=5.6.2.1; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10130};
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:P11387}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P11387}.
CC   -!- MISCELLANEOUS: Eukaryotic topoisomerase I and II can relax both
CC       negative and positive supercoils, whereas prokaryotic enzymes relax
CC       only negative supercoils.
CC   -!- SIMILARITY: Belongs to the type IB topoisomerase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L07777; AAB36608.1; -; mRNA.
DR   PIR; S72366; S72366.
DR   RefSeq; NP_001084031.1; NM_001090562.1.
DR   AlphaFoldDB; P41512; -.
DR   SMR; P41512; -.
DR   BioGRID; 100588; 1.
DR   MaxQB; P41512; -.
DR   PRIDE; P41512; -.
DR   GeneID; 399263; -.
DR   KEGG; xla:399263; -.
DR   CTD; 399263; -.
DR   Xenbase; XB-GENE-950006; top1.1.L.
DR   OrthoDB; 303947at2759; -.
DR   Proteomes; UP000186698; Chromosome 9_10L.
DR   Bgee; 399263; Expressed in gastrula and 19 other tissues.
DR   GO; GO:0005694; C:chromosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003917; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; IEA:UniProtKB-EC.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0006338; P:chromatin remodeling; ISS:UniProtKB.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0006265; P:DNA topological change; IEA:InterPro.
DR   CDD; cd00659; Topo_IB_C; 1.
DR   Gene3D; 1.10.10.41; -; 1.
DR   Gene3D; 1.10.132.10; -; 1.
DR   Gene3D; 2.170.11.10; -; 1.
DR   Gene3D; 3.90.15.10; -; 1.
DR   InterPro; IPR011010; DNA_brk_join_enz.
DR   InterPro; IPR013034; DNA_topo_DNA_db_N_dom1.
DR   InterPro; IPR013030; DNA_topo_DNA_db_N_dom2.
DR   InterPro; IPR001631; TopoI.
DR   InterPro; IPR018521; TopoI_AS.
DR   InterPro; IPR025834; TopoI_C_dom.
DR   InterPro; IPR014711; TopoI_cat_a-hlx-sub_euk.
DR   InterPro; IPR014727; TopoI_cat_a/b-sub_euk.
DR   InterPro; IPR013500; TopoI_cat_euk.
DR   InterPro; IPR008336; TopoI_DNA-bd_euk.
DR   InterPro; IPR036202; TopoI_DNA-bd_euk_N_sf.
DR   InterPro; IPR013499; TopoI_euk.
DR   Pfam; PF14370; Topo_C_assoc; 1.
DR   Pfam; PF01028; Topoisom_I; 1.
DR   Pfam; PF02919; Topoisom_I_N; 1.
DR   PRINTS; PR00416; EUTPISMRASEI.
DR   SMART; SM00435; TOPEUc; 1.
DR   SUPFAM; SSF56349; SSF56349; 1.
DR   SUPFAM; SSF56741; SSF56741; 1.
DR   PROSITE; PS00176; TOPOISOMERASE_I_EUK; 1.
PE   2: Evidence at transcript level;
KW   Biological rhythms; DNA-binding; Isomerase; Nucleus; Reference proteome;
KW   Topoisomerase.
FT   CHAIN           1..829
FT                   /note="DNA topoisomerase 1"
FT                   /id="PRO_0000145204"
FT   REGION          1..248
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          481..482
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   REGION          544..549
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   REGION          641..643
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        33..164
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        173..248
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        779
FT                   /note="O-(3'-phospho-DNA)-tyrosine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10130"
FT   SITE            372
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            420
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            468
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            499
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            557
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            588
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            630
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            688
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
FT   SITE            706
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   829 AA;  98231 MW;  8D1FE4252A916219 CRC64;
     MSEDHVQNDS QIEAVFRVND SHKHKKDKEH RHKEHKKDKD REKSKHNNSE HRDPSEKKHK
     DKHKNNDKHR EKDGEKHRER DGEKHRDKNG EKHRDGEKHK EKDIEKHKEV EKHRVKDGEK
     HKEKDVEKHK EKDVEKHRDG EKHKHRDKDR EKKKEEKMKS SSGGVKVKKE NGFSSPVRVK
     DEPEDQGFYV SPKENKAMKR PREDDEDYKP KKIKSEDDKK GKKRKQEEED IKPKKKSKAK
     GNEEGVKKKK VKKEEEEKWK WWEEERHRDG IKWKFLEHKG PVFAPPYEPV PDNVKFYYDG
     NLVKLSPKAE EVATFFAKML DHEYTTKDIF RKNFFKDWKK EMTTDERNLI TNLSKCDFNA
     MSLYFKEQSE ARKNMTKEEK LKIKAENERL LQEYGYCIMD NHKERIANFR IEPPGLFRGR
     GDHPKMGKLK KRIMPEDIII NCSKDSKIPV APAGHKWKEV RHDGKVTWLV SWTENIQGSI
     KYIMLNPSSR IKGEKDWQKY ETARRLKMCV EKIRNTYKED WKSKEMKVRQ RAVALYFIDK
     LALRAGNEKE EGETADTVGC CSLRVEHINL FQELDGQEFV VEFDFPGKDS IRYYNKVPVE
     KRVFKNLQLF MENKQPDDDL FDRLNTSILN KHLQDLMEGL TAKVFRTYNA SITLQQQLDE
     LTNSDDNVPA KILSYNRANR AVAILCNHQR APPKTFEKSM MNLQGKIDAK KDQLADARRE
     FKSAKADAKV RRDEKTKKLV ESKKKAVQRI EEQLMKLEVQ ATDREENKQI ALGTSKLNYL
     DPRISVAWCK KYGVPIEKIY NKTQRKNLLG PSIWQTTTSN FNAEQRCFS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024